How can I donate to this campaign?

Click on the 'Donate Now' button and follow the instructions to complete your donation securely.

Is my donation tax-deductible?

Yes, all donations made on ImpactGuru are eligible for tax exemption under Section 80G.

GEM : Give Every Month

GEM is a monthly donation subscription that helps you save patients in India with timely treatment.

GIVE EVERY MONTH

Fundraiser ended on Jul 28, 2026

Our 4 m/o baby Krishna loses his strength to SMA. Help now!

TAX BENEFITS

Indian tax benefits available

URGENT

GALLERY (3)

Campaigner Details

Verified

Phone Verified
Email Verified
Identity Verified

Venkatesh Pallapothala

Bengaluru Karnataka Contact

Beneficiary Details

Verified

Phone Verified
Identity Verified

Baby of anusha

Child of Venkatesh Pallapothala

Patient is currently not admitted

of $ 1,256,831

427,321 Donors

Funds will be transferred for patient's treatment

Campaigner Details

Verified

Phone Verified
Email Verified
Identity Verified

Venkatesh Pallapothala

Bengaluru Karnataka | Contact

Beneficiary Details

Verified

Phone Verified
Identity Verified

Baby of anusha

Child of Venkatesh Pallapothala

Patient is currently not admitted

Latest Update

Dear Donors,

I would like to share another important update on Baby Krishna's treatment journey.

Today, 30th July 2026, Baby Krishna's blood sample was collected for the antibody test, which is an important step in the process leading up to the Zolgensma gene therapy. We are now awaiting the test results, which will help the medical team determine the next steps in his treatment.

Every milestone we reach is because of your unwavering support, prayers, and generosity. Your kindness has given our family hope during one of the most challenging phases of our lives.

We will continue to keep you updated on Baby Krishna's progress. Thank you for believing in our son and standing with us every step of the way.

With heartfelt gratitude,
Krishna's Father & Family

Story

“As a father, my only dream is to see my son grow up healthy and achieve everything life has to offer.” - Venkatesh Pallapothala, father.

We were overjoyed when our little Krishna came into our lives. Like every parent, we dreamed of watching him crawl, play, and grow up with his elder brother. But, everything changed when Krishna was diagnosed with Spinal Muscular Atrophy (SMA) Type 1 on April 7th, 2026.

SMA Type 1 is a rare genetic disorder that affects his muscles and takes away his ability to move normally.

Today, our 4-month-old Krishna cannot move his hands and legs like other babies. He has no head control and struggles with breathing. He has also been started on BiPAP support due to respiratory difficulties.

“My baby is too young to understand his pain, but I see his struggle every day.” - Anusha Pallapothala, mother.

Doctors have advised urgent gene therapy with Zolgensma, a one-time treatment that could help slow the progression of this disease. But Krishna needs to receive this treatment before he turns 6 months old!

The rising exchange rate has made our journey even more difficult, increasing our goal to ₹11 crore. This amount will help ensure our child receives both the life-saving treatment and the vital care needed after the procedure.

We are a middle-class family, and I am the only earning member supporting our family of seven. We have already spent nearly ₹8 lakhs on Krishna’s treatment using our savings, but the cost of his life-saving treatment is beyond what we can manage alone.

Our only dream is to see Krishna survive, grow stronger, and one day live independently like every other child.

Your donation and sharing of our baby Krishna’s story can help us bring him closer to the life-saving treatment he deserves.

How can you help?

Donate to his treatment.

By donating, you help ensure that he receives the treatment that saves his life.

Share his story with your family and friends.

By sharing his story with your loved ones and friends, you will help to amplify his voice to those who care and are willing to donate.

*******

4 ತಿಂಗಳ ಕೃಷ್ಣನಿಗೆ SMA ಟೈಪ್ 1 ಇದೆ, ಏಪ್ರಿಲ್ 2026 ರಲ್ಲಿ ಪತ್ತೆಯಾಗಿದೆ.

ಅವನಿಗೆ ಕೈಕಾಲು ಚಲನೆ, ಉಸಿರಾಟದ ತೊಂದರೆ ಮತ್ತು ತಲೆ ನಿಯಂತ್ರಣವಿಲ್ಲ.

ಮುಂದಿನ 2 ತಿಂಗಳೊಳಗೆ ಅವನಿಗೆ ತುರ್ತಾಗಿ ₹9.5 ಕೋಟಿ ಝೋಲ್ಜೆನ್ಸ್ಮಾ ಜೀನ್ ಚಿಕಿತ್ಸೆಯ ಅಗತ್ಯವಿದೆ!

ನಿಮ್ಮ ಬೆಂಬಲ ಸ್ವಲ್ಪ ಜೀವಕ್ಕೆ ಸಹಾಯ ಮಾಡಬಹುದು. ಈಗಲೇ ದೇಣಿಗೆ ನೀಡಿ!

ನೀವು ಹೇಗೆ ಸಹಾಯ ಮಾಡಬಹುದು?

ಅವರ ಚಿಕಿತ್ಸೆಗೆ ದೇಣಿಗೆ ನೀಡಿ.

ದೇಣಿಗೆ ನೀಡುವ ಮೂಲಕ, ಅವರ ಜೀವವನ್ನು ಉಳಿಸುವ ಚಿಕಿತ್ಸೆಯನ್ನು ಅವರು ಪಡೆಯುವುದನ್ನು ಖಚಿತಪಡಿಸಿಕೊಳ್ಳಲು ನೀವು ಸಹಾಯ ಮಾಡುತ್ತೀರಿ.

ಅವರ ಕಥೆಯನ್ನು ನಿಮ್ಮ ಕುಟುಂಬ ಮತ್ತು ಸ್ನೇಹಿತರೊಂದಿಗೆ ಹಂಚಿಕೊಳ್ಳಿ.

ಅವರ ಕಥೆಯನ್ನು ನಿಮ್ಮ ಪ್ರೀತಿಪಾತ್ರರು ಮತ್ತು ಸ್ನೇಹಿತರೊಂದಿಗೆ ಹಂಚಿಕೊಳ್ಳುವ ಮೂಲಕ, ಕಾಳಜಿ ವಹಿಸುವ ಮತ್ತು ದೇಣಿಗೆ ನೀಡಲು ಸಿದ್ಧರಿರುವವರಿಗೆ ಅವರ ಧ್ವನಿಯನ್ನು ವರ್ಧಿಸಲು ನೀವು ಸಹಾಯ ಮಾಡುತ್ತೀರಿ.

The goal amount of the campaign may be higher than the attached estimates to address and aid the post-hospitalization expenses/contingencies including but not limited to prolonged medication, diagnostics, rehabilitation therapies, and follow-up doctor visits/consultations which vary from disease to disease.

NO INFLUENCE DECLARATION
Impact Guru does not influence / control the decision of the campaigner / patient with respect to choice of hospital / doctor / healthcare treatment or the cost / estimate of any such treatment. Such decision is in entirety of campaigner / patient / beneficiary and / or their family members without any interference and / or say of Impact Guru. Impact Guru is absolved of any liability in respect thereof.

LANGUAGE OF STORY/STATEMENT DECLARATION
The language, story, facts mentioned on this fundraising page is in entirety statements / opinions / thoughts shared by the campaigner / beneficiary or persons authorised on their behalf and shall not be construed as statement / thoughts / opinions of or on behalf of Impact Guru.

TREATMENT COST ESTIMATES
Impact Guru has no control over the cost estimates provided by hospitals / clinics / pharmaceutical companies etc. The cost estimates vary depending on the city and / or hospital where the patient is under treatment, professional fees of the treating doctors, drugs / medicines / therapies chosen for treatment by patient or patient’s family at their own discretion including but not limited to unique medical conditions / circumstances pertaining to each patient.

UTILIZATION OF FUNDS
In the rare scenario of surplus funds remaining within the fundraising campaign due to any of the following circumstances:
i) Completion of the Patient's treatment; ii) Receipt of requisite funding for the Patient from alternative sources; iii) Eligibility of the Patient for free treatment under any scheme or the receipt of free treatment by other means; iv) Demise of the Patient; v) Fulfilment of the fundraising campaign's objectives; vi) Termination of the fundraising campaign for any reason; vii) Reduction in the cost of the drug/therapy required for SMA treatment; viii) Prescription of an alternative therapy for the Patient's treatment
Impact Guru shall ensure that such surplus funds are allocated for the following purposes:
i) Provision of alternative drug therapy treatments as prescribed by the attending physician for the Patient/s (if applicable). Such utilization may span across multiple years, as SMA therapies/treatments typically entail long-term, recurring costs; ii) If surplus funds persist even after the aforementioned allocation, they shall be employed to assist other patients on Impact Guru in their life-saving treatment, with the objective of maximizing social impact; iii) donors of the fundraising campaign at the sole discretion of Impact Guru may be offered the option to claim a pro-rata refund of surplus funds.

PATIENT DEATH UPDATE
Upon the death of the patient, the Campaigner / close relative / POC on behalf of the patient shall be duty bound to inform Impact Guru immediately within two (2) hours of such occurrence and turn off the donations tab (through the internal access granted) on the campaign on Impact Guru Platform in order to stop fundraising on the campaign. In the event Campaigner or authorised/designated POC on behalf of the patient fails to do so and campaign continues raising funds due to such non-information/non action, the Campaigner or authorised/designated POC on behalf of the patient shall be personally liable any consequences thereof; further, Impact Guru shall be disclaimed of all the liabilities occurring with respect to such post death fundraising and the such liability in entirety shall accrue on Campaigner or authorised/designated POC on behalf of the patient. In the event of death of the patient, Impact Guru’s Patient Death Policy at Terms Of Use shall apply.

Documents

Updates(6)

#1 (30 Jul, 2026) - From Venkatesh Pallapothala

Dear Donors,

I would like to share another important update on Baby Krishna's treatment journey.

Every milestone we reach is because of your unwavering support, prayers, and generosity. Your kindness has given our family hope during one of the most challenging phases of our lives.

We will continue to keep you updated on Baby Krishna's progress. Thank you for believing in our son and standing with us every step of the way.

With heartfelt gratitude,
Krishna's Father & Family

#2 (29 Jul, 2026) - From Venkatesh Pallapothala

Dear Donors,

From the bottom of my heart, I want to thank each one of you for your generosity, prayers, and unwavering support. Because of your kindness, my son, Baby Krishna, has been given hope and a chance at a healthier future.

I am happy to share an important update with you.

On 28th July, we met Dr. Prabhu to begin the process for Zolgensma gene therapy. This was a significant milestone for our family, and we are grateful to have reached this stage because of your support.

At present, Baby Krishna is continuing his Risdiplam treatment at Aster CMI Hospital while the doctors complete the necessary medical evaluations and procedures required before administering Zolgensma. These assessments are essential to ensure that the treatment is carried out safely and at the right time.

We know there is still a journey ahead, but every step forward fills us with hope. We will continue to keep you updated on Baby Krishna's progress.

Thank you for believing in my son and standing with our family during this difficult time. Your kindness has given us strength, hope, and the courage to keep moving forward. We will forever be grateful for your love and support.

With heartfelt gratitude,
Venkatesh Pallapothala (Krishna's Father)

#3 (24 Jul, 2026) - From Venkatesh Pallapothala

Dear Donors,

We would like to share an important update regarding the treatment budget for the campaign.

To ensure complete transparency, the campaign goal has been updated, reflecting both the cost of gene therapy and the essential long-term medical care required for the treatment journey.

The revised estimate includes ₹9.8 crore for the one-time cost of Zolgensma (this medicine needs to be imported and prices may vary with the exchange rate), ₹40L-₹1cr+ towards Risdiplam medication (estimated for at least five to ten years and costs may vary depending on the procurement and availability of generic or branded medicine), ₹20L-₹30L for prolonged physiotherapy, speech therapy, rehabilitation and medical equipments for five to ten years, and ₹20L-₹40L to cover contingencies and hospitalisation as health insurance currently does not cover expenses on account of the genetic disorder.

This revised goal is intended to ensure that the campaign covers not only the one-time cost of Zolgensma but also the critical follow-up treatment, rehabilitation, and medical support required to maximise the benefits of the therapy and provide the best possible outcome. Any unutilized funds shall be employed to assist other SMA patients on Impact Guru in their life-saving treatment in line with the platform policies, with the objective of maximizing social impact.

We remain deeply grateful for the trust, generosity, and encouragement shown by each of our donors. Your support is making this life-changing treatment possible, and every contribution brings us one step closer to giving hope for a healthier future.

Thank you for standing with us throughout this journey.

#4 (10 Jul, 2026) - From Venkatesh Pallapothala

Dear Donors

The Baby of Anusha is currently at home and is not admitted to the hospital.

Medications and regular doctor follow-ups are ongoing, and the baby's condition is being closely monitored.

The doctors have advised gene therapy, which will be undertaken once the required funds are available.

Your support is crucial at this stage. Please consider making a donation to help make this life-saving treatment possible.

Every contribution brings the baby one step closer to receiving the needed care.

#5 (12 Jun, 2026) - From Venkatesh Pallapothala

Dear Donors,

Baby of Anusha is currently not admitted to the hospital and continues to receive treatment on an outpatient basis.

His medication and follow-up consultations are ongoing as advised by the medical team.

We remain hopeful for his continued improvement and recovery.

Your generous support is greatly appreciated.

Please consider donating and sharing his appeal.

#6 (11 Jun, 2026) - From Venkatesh Pallapothala

Dear Donors,

4-month-old Krishna battles SMA Type 1, diagnosed on April 7th, 2026. He currently has limited movement in his limbs, no head control, and breathing difficulties requiring BiPAP support. Doctors have urgently advised Zolgensma gene therapy before Krishna turns 6 months old. Your support can help give him a chance at life. Donate and share Krishna’s story.